Search results
Results from the WOW.Com Content Network
pimobendan – phosphodiesterase 3 inhibitor used to manage heart failure in dogs; pirlimycin – antimicrobial; ponazuril – anticoccidial; praziquantel – treatment of infestations of the tapeworms Dipylidium caninum, Taenia pisiformis, Echinococcus granulosus; prazosin – sympatholytic used in hypertension and abnormal muscle contractions
Maropitant (INN; [3] brand name: Cerenia, used as maropitant citrate , is a neurokinin-1 (NK 1) receptor antagonist developed by Zoetis specifically for the treatment of motion sickness and vomiting in dogs. It was approved by the FDA in 2007, for use in dogs [4] [5] and in 2012, for cats. [6]
Owners turn to radiation treatment. In Breinigsville, Pennsylvania, 9-year-old Cinder, a Labrador, was on five daily oral medications for severe arthritis that developed when she was five.
Dr. Mark answers a pet owner's question about a dog with limping and dragging legs. ... Vet-Approved Home Treatment for Senior Dogs with Arthritis. Dr. Mark dos Anjos. December 27, 2024 at 8:05 AM ...
Clozapine, sold under the brand name Clozaril among others, is a psychiatric medication and was the first atypical antipsychotic to be discovered. [6] It is primarily used to treat people with schizophrenia and schizoaffective disorder who have had an inadequate response to two other antipsychotics, or who have been unable to tolerate other drugs due to extrapyramidal side effects.
Hypersalivation can contribute to drooling if there is an inability to keep the mouth closed or difficulty in swallowing (dysphagia) the excess saliva, which can lead to excessive spitting. Hypersalivation also often precedes emesis (vomiting), where it accompanies nausea (a feeling of needing to vomit).
It is the company's first product in the market related to skin disease treatments for dogs, that include Zoetis' oral treatment Apoquel. In a head-to-head study conducted in 338 dogs, Zenrelia ...
Quetiapine and clozapine are considered the lowest risk agents for precipitating TD. [25] From 2008, there have been reported cases of the anti-psychotic medication aripiprazole, a partial agonist at D2 receptors, leading to tardive dyskinesia. [26] As of 2013, reports of tardive dyskinesia in aripiprazole have grown in number. [27]